(UNH) UnitedHealth - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US91324P1021
UNH: Health Insurance, Healthcare Services, IT Solutions, Pharmacy Services
UnitedHealth Group Incorporated (NYSE:UNH) is a diversified health care company operating in the United States and internationally. The company is structured into four distinct business segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. UnitedHealthcare is the largest segment, offering a wide range of health benefit plans and services, including individual and employer-sponsored plans, Medicare Advantage, Medicaid, and specialized programs for underserved populations. Optum Health focuses on care delivery and management, providing wellness programs, consumer engagement, and financial services to patients, providers, and payers. Optum Insight delivers software solutions, consulting services, and outsourcing contracts to healthcare organizations, governments, and life sciences companies. Optum Rx specializes in pharmacy care services, including retail and specialty pharmacy programs, drug adherence management, and formulary optimization. Founded in 1974, the company is headquartered in Eden Prairie, Minnesota.
Additional Sources for UNH Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
UNH Stock Overview
| Market Cap in USD | 386,163m |
| Sector | Healthcare |
| Industry | Healthcare Plans |
| GiC Sub-Industry | Managed Health Care |
| IPO / Inception | 1984-10-26 |
UNH Stock Ratings
| Growth Rating | 46.9 |
| Fundamental | 53.6 |
| Dividend Rating | 66.1 |
| Rel. Strength | -15.6 |
| Analysts | 4.63/5 |
| Fair Price Momentum | 410.49 USD |
| Fair Price DCF | 499.95 USD |
UNH Dividends
| Dividend Yield 12m | 1.79% |
| Yield on Cost 5y | 3.18% |
| Annual Growth 5y | 11.11% |
| Payout Consistency | 95.3% |
UNH Growth Ratios
| Growth Correlation 3m | -21.1% |
| Growth Correlation 12m | -0.5% |
| Growth Correlation 5y | 83.4% |
| CAGR 5y | 9.13% |
| CAGR/Max DD 5y | 0.27 |
| Sharpe Ratio 12m | 0.52 |
| Alpha | -21.24 |
| Beta | 0.351 |
| Volatility | 40.68% |
| Current Volume | 8823.6k |
| Average Volume 20d | 7987.4k |
As of April 30, 2025, the stock is trading at USD 409.23 with a total of 8,823,600 shares traded.
Over the past week, the price has changed by -4.20%, over one month by -21.87%, over three months by -23.62% and over the past year by -14.98%.
Partly, yes. Based on ValueRay Fundamental Analyses, UnitedHealth (NYSE:UNH) is currently (April 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 53.61 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of UNH as of April 2025 is 410.49. This means that UNH is currently overvalued and has a potential downside of 0.31%.
UnitedHealth has received a consensus analysts rating of 4.63. Therefor, it is recommend to buy UNH.
- Strong Buy: 19
- Buy: 6
- Hold: 2
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, UNH UnitedHealth will be worth about 443.3 in April 2026. The stock is currently trading at 409.23. This means that the stock has a potential upside of +8.33%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 568.7 | 39% |
| Analysts Target Price | 636.8 | 55.6% |
| ValueRay Target Price | 443.3 | 8.3% |